KAT2A and cancer: These results demonstrated that KAT2A may promote the expression of UBE2C through combining with E2F1 to the E2F1 binding site on UBE2C promoter −322/+39 region to increase the acetylation level of H3K9, and consequently stimulated cancer cell proliferation and migration.